<DOC>
	<DOC>NCT03042416</DOC>
	<brief_summary>Single centre prospective cohort phase III study of 18F-DOPA PET/CT imaging in specific patient populations: 1. Pediatric patients with congenital hyperinsulinism 2. Pediatric patients with neuroblastoma 3. Pediatric or Adult patients with suspected extra-pancreatic neuroendocrine tumor 4. Adult patients with a clinical suspicion of Parkinson's disease 5. Pediatric or Adult patients with primary brain tumors This study will evaluate the biodistribution and safety of 18F-DOPA produced at the Edmonton PET Centre.</brief_summary>
	<brief_title>18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Hyperinsulinism</mesh_term>
	<mesh_term>Congenital Hyperinsulinism</mesh_term>
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<criteria>1. Pediatric patients (less than 17 years old) with congenital hyperinsulinism 2. Pediatric patients (less than 17 years old) with neuroblastoma 3. Pediatric patients (less than 17 years old) or Adult patients (17 or older) with known or clinically suspected neuroendocrine tumor outside of the pancreas 4. Adult patients (17 or older) with a clinical suspicion of Parkinson's disease. 5. Pediatric (less than 17 years old) or Adult patients (17 or older) with primary brain tumors Unable to obtain consent Weight &gt; 250 kg (weight limitation of PET/CT scanner) Adult patients unable to lie flat for 2030 minutes to complete the PET/CT scan Young pediatric patients (less than 10 years old) who are unable to lie flat for 2030 minutes and for whom clinical sedation is contraindicated (as determined by a pediatric anaesthesiologist) Pregnancy Lack of intravenous access</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>18F-DOPA PET/CT</keyword>
</DOC>